Security key
45783C200
Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (TIL)
CUSIP: 45783C200
Q2 2025 13F Holders as of 30 Jun 2025
- Security type / class
- Equity / Common stock, par value $ 0.000001 per share
- Total 13F shares
- 2,751,266
- Total 13F value
- $57,311,087
- Share change
- -596,529
- SEC-reported price per share
- $20.83
- Number of holders
- 37
- Value change
- -$11,020,093
- Number of buys
- 16
- Number of sells
- 24
- Shares outstanding
- 6,505,400
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2025
Institutions
37
Top holders
10
TIL full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q3 2025
Previous quarter: Q1 2025
Instil Bio, Inc. SEC filings
Instil Bio, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 45783C200
Recent filing periods:
Ownership snapshot
Top reported holders of TIL - Instil Bio, Inc. - Common stock, par value $ 0.000001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Vivo Capital IX, LLC
Disclosed value leader
Curative Ventures V LLC
Comparable rows
15/15
Latest evidence
30 Jun 2025
13D/G
13F
Lead comparable stake: 4.5%
13D/G row: Vivo Capital IX, LLC
Showing 1-6 of 15 holder rows.
Quick read
Vivo Capital IX, LLC leads the comparable SEC ownership view at 4.5%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Vivo Capital IX, LLC's linked filing trail.
Comparable ownership
Top 5
Vivo Capital IX, LLC
4.5%
Curative Ventures V LLC
28%
Vivo Capital, LLC
9%
BML Capital Management, LLC
6.4%
CPMG Inc
6.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Vivo Capital IX, LLC |
13D/G
|
4.5%
|
$7,169,276
292,743 shares
|
$0 | 30 Jun 2025 |
| Curative Ventures V LLC |
13F
Company
|
28%
|
$32,966,709
1,899,004 shares
|
— | 31 Mar 2025 |
| Vivo Capital, LLC |
13F
Company
|
9%
|
$10,164,020
585,485 shares
|
— | 31 Mar 2025 |
| BML Capital Management, LLC |
13F
Company
|
6.4%
|
$7,234,259
416,720 shares
|
— | 31 Mar 2025 |
| CPMG Inc |
13F
Company
|
6.3%
|
$7,133,606
410,922 shares
|
— | 31 Mar 2025 |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
Company
|
4.9%
|
$5,508,745
317,324 shares
|
— | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
37
Shares
2,751,266
Rows available
37
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
42
Q2 2025 holders
37
Holder diff
-5
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q2 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend